Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer
Circulating cell-free DNA (cfDNA) in ampullary cancer patients was measured to clarify the correlation between cfDNA and clinicopathological factors and the impact of cfDNA on survival outcomes. Patients with ampullary cancer undergoing pancreaticoduodenectomy were included. Correlations between cfD...
Main Authors: | Bor-Uei Shyr, Bor-Shiuan Shyr, Shih-Chin Chen, Shih-Ching Chang, Yi-Ming Shyr, Shin-E Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/10/2313 |
Similar Items
-
Pylorus preserving pancreaticoduodenectomy for peri-ampullary carcinoma, is it a good option?
by: Alsaif Faisal
Published: (2010-01-01) -
Robotic pancreaticoduodenectomy for pancreatic head cancer and periampullary lesions
by: Yi‐Ming Shyr, et al.
Published: (2021-09-01) -
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
by: Morten Lapin, et al.
Published: (2018-11-01) -
Endoscopic versus surgical treatment of ampullary adenomas: a systematic review and meta-analysis
by: Ernesto Quaresma Mendonça, et al.
Published: (2016-01-01) -
Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review
by: Adrian Martuszewski, et al.
Published: (2021-01-01)